Ask about purpose, phase, known/unknown risks, alternatives, visits, biopsies, anesthesia, contraception, costs, privacy, withdrawal, injury coverage, post-trial access and who handles emergencies.
What this means in real life
Informed consent should explain the study’s purpose, phase, procedures, foreseeable risks, unknowns, alternatives, privacy, costs, injury policy and the right to withdraw. For children, parents generally provide permission and the child may provide assent in language suited to development. Consent is a process, not a one-time signature, and families can ask for more time or another discussion.
Separate research from treatment. Ask which procedures exist only to produce research data, such as extra biopsies, imaging or blood draws, and which may directly help clinical care. Early-phase studies often focus mainly on dose and safety; benefit may be uncertain even when the scientific idea is promising.
Read the injury and cost sections closely. The form may not promise compensation for research injury. Ask who pays for routine care, travel, complications and long-term follow-up, and what happens to samples and data after withdrawal.
A practical checklist
- ✓
Take the consent form home when possible and mark unclear language.
- ✓
Create a visit/procedure calendar including anesthesia, biopsies and follow-up years.
- ✓
Compare trial participation with standard-care and other-trial alternatives.
- ✓
Review costs, injury coverage, privacy and withdrawal consequences.
- ✓
Invite the child or adult participant to express goals and limits.
Questions to bring with you
Use these at the clinic, school meeting, equipment evaluation, program interview or benefits call. Write down the answers and who owns the next step.
- What is the primary purpose and phase of this study?
- Which risks are known, theoretical or still unknown?
- Which procedures are research-only?
- What happens medically and financially after withdrawal or injury?
- What access, if any, exists after the trial ends?
Important context
Individual needs, eligibility and safety can differ. Confirm the plan with the relevant Duchenne-experienced clinician, therapist, school team or program before acting.
Sources used for this guide
Direct links are included so families can check the original guidance and bring it to qualified professionals.
Content review: July 18, 2026. Medical labels, trials, benefits and programs can change after publication.
Did this article answer the question?
A thumbs-down sends the article to the private administrator dashboard for review.